BDMD director reports 25,000 RSU shares

Baird Medical Investment Holdings Ltd director Xu Lijian filed an initial statement of beneficial ownership.

Accepted by SEC EDGAR 04/21/2026 - 06:07 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Baird Medical Investment Holdings Ltd director Xu Lijian filed an initial statement of beneficial ownership. The filing reports direct ownership of 25,000 RSU Shares (BDMD), indicating Xu’s equity position in the company through restricted stock unit shares.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Xu Lijian

Role Director

Type	Security	Shares	Price	Value
Holding	RSU Shares (BDMD)	--	--	--

Holdings: RSU Shares (BDMD) — 25,000 shares (Direct)

Key Figures

RSU share holdings: 25,000 RSU Shares (BDMD)

1 metrics

RSU share holdings 25,000 RSU Shares (BDMD) Total shares following reporting of holdings by director Xu Lijian

Key Terms

RSU Shares (BDMD), beneficial ownership, direct ownership

3 terms

RSU Shares (BDMD) financial

"The filing reports direct ownership of 25,000 RSU Shares (BDMD)."

beneficial ownership financial

"The filing reports an initial statement of beneficial ownership."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

direct ownership financial

"The entry indicates direct ownership of the RSU Shares (BDMD)."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BDMD Form 3 filing by Xu Lijian report?

The Form 3 filing reports that director Xu Lijian beneficially owns 25,000 RSU Shares (BDMD). This establishes Xu’s initial disclosed equity position in Baird Medical Investment Holdings Ltd as a company insider.

How many BDMD shares does Xu Lijian report owning on Form 3?

The filing shows that Xu Lijian directly owns 25,000 RSU Shares (BDMD). These are restricted stock unit shares and represent Xu’s reported beneficial ownership position as of the Form 3 filing date.

Is the BDMD Form 3 for Xu Lijian a buy or sell transaction?

The Form 3 for Xu Lijian does not report a buy or sell. It is an initial beneficial ownership statement showing holdings of 25,000 RSU Shares (BDMD), rather than a new purchase or sale.

What type of security is reported for Xu Lijian in BDMD’s Form 3?

The security reported is RSU Shares (BDMD), meaning restricted stock unit shares of Baird Medical Investment Holdings Ltd. The filing lists 25,000 such shares held directly by director Xu Lijian.

Does the BDMD Form 3 indicate direct or indirect ownership for Xu Lijian?

The Form 3 shows direct ownership for Xu Lijian. The entry for RSU Shares (BDMD) indicates 25,000 shares held with a direct ownership code, reflecting Xu’s personal beneficial interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Xu Lijian

(Last) (First) (Middle)

15 RONG TONG STREET

(Street)

GUANGZHOU GUANGDONG 510030

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/21/2026

3. Issuer Name and Ticker or Trading Symbol
Baird Medical Investment Holdings Ltd [ BDMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
RSU Shares (BDMD)	25,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ XU LIJIAN	04/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)